Quick search for therapies
3 results (filtered)
Page 1 / 1
1
Honarmand, K.; Tierney, M.C.; O'Connor, P.; Feinstein, A.
Effects of cannabis on cognitive function in patients with multiple sclerosis
Neurology, 2011, 76(13), 1153-1160
Effects of cannabis on cognitive function in patients with multiple sclerosis
Neurology, 2011, 76(13), 1153-1160
Anxiety, Cannabis, Depression, Clinical research, Complementary and alternative medicine, Multiple sclerosis, Nervous system, Non-randomized trial, Phytomedicine, Mental diseases
2
Stürner, K.H.; Stellmann, J.-P.; Dörr, J.; Paul, F.; Friede, T.; Schammler, S.; Reinhardt, S.; Gellissen, S.; Weissflog, G.; Feizy, T.D.; Werz, O.; Fleischer, S.; Vaas, L.A.I.; Herrmann, F.; Pless, O.; Martin, R.; Heesen, C.
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
J Neurol Neurosurg Psychiatry, 2018, 89(4), 330-338
A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
J Neurol Neurosurg Psychiatry, 2018, 89(4), 330-338
Observational trial, Boswellia, Clinical research, Complementary and alternative medicine, Multiple sclerosis, Nervous system, Phytomedicine
3
Kindred, J.H.; Honce, J.M.; Kwak, J.J.; Rudroff, T.
Multiple sclerosis, cannabis use, and clinical disability
A preliminary [18F]-Fluorodeoxyglucose positron emission tomography study
Cannabis Cannabinoid Res, 2018, 3(1), 213-218
Multiple sclerosis, cannabis use, and clinical disability
A preliminary [18F]-Fluorodeoxyglucose positron emission tomography study
Cannabis Cannabinoid Res, 2018, 3(1), 213-218
Observational trial, Brain, Clinical research, Complementary and alternative medicine, Multiple sclerosis, Nervous system, Phytomedicine